Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Challenges in the treatment of psoriasis

Challenges in the treatment of psoriasis
Share on FacebookShare on Twitter

The financial burden and ineffective treatment represent Malaysia’s most significant challenges in treating psoriasis. Findings from the “Psoriasis Patient Access Education Survey”, conducted in August 2022 by an international joint survey on psoriasis patients in Korea, Hong Kong and Malaysia, revealed that 53 per cent of respondents in Malaysia identified financial burden, followed by ineffective treatment (49 per cent) and inconvenient/unacceptable waiting time to see a healthcare provider (39 per cent) as key challenges.

According to Psoriasis Association of Malaysia (PAM) President Major (Rtd) Eugene Cross: “The patient survey findings are in line with the feedback we receive from our members. Among our members who have been affected seriously with widespread skin lesions or autoimmune arthritis symptoms – a category of medicine called biologics can provide adequate relief for the majority. However, this therapy is not a cure; patients need ongoing treatment. Moreover, biologics treatment is costly – estimated to vary between RM30,000 and RM50,000 annually.”

The continued failure to address these funding and regulatory issues has resulted in a lower proportion of Malaysian patients (14 per cent) receiving the latest treatment compared to their counterparts in Korea (37 per cent) and Hong Kong (55 per cent).

The findings of this patient survey were released in conjunction with the World Psoriasis Day (WPD) celebration in Malaysia on Oct 30, 2022.

Psoriasis is a debilitating auto-immune and chronic inflammatory disease affecting the skin and joints. In Malaysia, about 23,800 patients with psoriasis were recorded in the National Registry from October 2007 – December 2019, although it is broadly estimated that the disease affects around 300,000 Malaysians. This year’s WPD theme is “United We Tackle Mental Health” since mental health is increasingly recognised as a significant part of living with psoriatic disease.

“The public may not realise that many psoriasis patients are not only affected physically, but emotional scarring is also common among patients. Combining the mental health and financial aspect with the physical symptoms all add up to a patient’s heavy burden.

“Much needs to be done for psoriasis patients in Malaysia. PAM hopes to continue finding long-term solutions with the relevant health players to address the plight of psoriasis patients in our country,” said Dr K Thiruchelvam, Deputy President of PAM.

Several activities were organised- including a fashion show, photography exhibition and skin clinics – to highlight public awareness of this skin condition. The event was supported by a number of organisations, including Boehringer-Ingelheim, Novartis, AbbVie, Leo Pharma, Johnson and Johnson, Fresenius Kabi, Suu Balm, MooGoo, Hospital Kuala Lumpur, Hospital Ampang, MACP, RPM, PPM.

Tags: HealthcareLocal NewsPsoriasisThe Health 2022The Health NovThe Health Nov 2022theHealthWorld Psoriasis Day (WPD)
Previous Post

SEERS expands its health hubs

Next Post

Duopharma inks deal with SCM Lifescience

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Moderna sues Pfizer, BioNTech for patent infringement
    December 19, 2022
    Moderna said it was suing rival vaccine makers Pfizer and BioNTech, alleging […]
  • IJN and Novartis tackle heart disease
    December 21, 2022
    The National Heart Institute (IJN) and multinational pharmaceutical firm […]
  • Future-proofing public healthcare
    August 16, 2022
    There is a need to shift from a curative and treatment-focused mindset to a […]
  • Komarkcorp expands face mask business
    September 30, 2021
    PACKAGING solution provider and automatic labeling machine manufacturer […]
  • A new mountain to climb
    June 29, 2022
    A cancer patient’s journey, from choosing to be a Thriver instead of a Survivor […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist